Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New registry helps hospitals expand outpatient services for heart patients
The initiation of the ACC Ambulatory Surgical Center Registry comes at a time when hospitals are expanding their structural heart programs. The registry is providing valuable details about which patients should stay at the hospital and which can be treated in an outpatient setting.
FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Joysticks recalled after power wheelchairs move on their own, injuring a patient
The U.S. Food and Drug Administration announced a recall of Mo-Vis BVBA joysticks after a faulty firmware version was linked to the malfunction. Users will need to have their devices upgraded.
FDA approves nasal spray for edema associated with congestive heart failure
The newly approved intranasal loop diuretic can also be used to treat edema in patients with liver and kidney disease.
Cardiologists lead charge for medical device approvals in Europe to be more rigorous
There is a belief among some clinicians that it is too easy for companies to gain CE mark approval for their medical devices. However, a new proposal from the European Society of Cardiology and other groups could help change that.

A milestone for Medtronic: Low-risk TAVR patients treated with Evolut ‘doing exceptionally well’ after 2 years

The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients.

Abbott’s new self-expanding TAVR system gains CE mark approval

The solution has still only been approved in the United States for investigational use.

Finerenone limits AFib in patients with chronic kidney disease, Type 2 diabetes

This secondary analysis of data from the FIDELIO-DKD trial was presented May 17 at ACC.21 and published in the Journal of the American College of Cardiology.

Alcohol—even just one drink—increases the risk of AFib

The study's authors believe they are the first group to investigate the real-time relationship between alcohol consumption and AFib events.

Full COVID-19 vaccination to be required at HIMSS21 in Las Vegas

The new requirement covers all attendees, including exhibitors and HIMSS employees. The organization is still determining how it will validate each person's status.

The greatest benefit: Omecamtiv mecarbil improves outcomes the most for patients with severe heart failure

Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil.

LAAO significantly lowers the risk of stroke after surgery among heart rhythm patients

“This is a procedure that’s done once, and it keeps giving a benefit over time,” one researcher said. “This is going to prevent thousands of strokes.”

FDA announces recall of more than 60,000 Abbott pacemakers due to risk of electrical short

The FDA has received complaints about 135 injuries so far.

Clinical

New registry helps hospitals expand outpatient services for heart patients

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Joysticks recalled after power wheelchairs move on their own, injuring a patient

FDA approves nasal spray for edema associated with congestive heart failure

Cardiologists lead charge for medical device approvals in Europe to be more rigorous